Business
Weight-Loss Drugs and AI Breakthroughs
Countries like Canada and India are set to gain access to cheaper generics of weight-loss drugs, while a new drug called retatrutide advances towards FDA approval. Meanwhile, an AI has solved a long-standing mathematical problem.
Coverage timeline — 3 articles
Scientific American
A chatbot’s result for the 80-year-old “unit distance” conjecture is the first AI proof that would likely be published in math’s top journal if humans had done it alone
2026-05-21 14:47 UTC
Scientific American
While drugs such as Wegovy target a single gut hormone, retatrutide is among a new class of GLP-1 drugs that aims at three hormone receptors
2026-05-21 15:30 UTC
MarketWatch
Over the next year, countries that are home to 40% of the world’s population are set to get access to Ozempic and Wegovy generics that could cost as little as $15 a month.
2026-05-21 16:15 UTC